Skip to main content
. 2021 May 11;12:652867. doi: 10.3389/fneur.2021.652867

Table 4.

Multivariate analysis including biomarkers, leukoaraiosis and leukoaraiosis degree. Dependent variable: Recurrence.

Not adjusted Adjusted
OR CI 95% p value OR CI 95% p value
MODEL A
Anticoagulants 3.65 2.16 - 6.20 <0.0001 3.64 2.09 - 6.31 <0.0001
Leukocytes 1.14 1.07 - 1.20 <0.0001 1.11 1.05 - 1.17 <0.0001
Effective reperfusion 0.51 0.34 - 0.77 0.001 0.64 0.42 - 0.98 0.041
sTWEAK ≥ 7,000 pg/mL 2.89 1.96 - 4.27 <0.0001 2.48 1.65 - 3.72 <0.0001
MODEL B
Anticoagulants 3.65 2.16 - 6.20 <0.0001 3.64 2.08 - 6.41 <0.0001
Leukocytes 1.14 1.07 - 1.20 <0.0001 1.10 1.04 - 1.17 0.001
Effective reperfusion 0.51 0.34 - 0.77 0.001 0.68 0.44 - 1.05 0.083
Leukoaraiosis 4.58 2.78 - 7.54 <0.0001 3.34 1.94 - 5.76 <0.0001
sTWEAK ≥ 7,000 pg/mL 2.89 1.96 - 4.27 <0.0001 1.62 1.04 - 2.53 0.032
MODEL C
Anticoagulants 3.65 2.16 - 6.20 <0.0001 3.52 1.96 - 6.34 <0.0001
Leukocytes 1.14 1.07 - 1.20 <0.0001 1.08 1.02 - 1.15 0.014
Effective reperfusion 0.51 0.34 - 0.77 0.001 0.96 0.59 - 1.56 0.872
Leukoaraiosis degree
- Grade I 2.26 1.18 - 3.99 0.005 2.42 1.34 - 4.33 0.003
- Grade II 6.05 3.33 - 10.98 <0.0001 6.20 2.91 - 13.17 <0.0001
- Grade III 25.87 13.04 - 51.36 <0.0001 29.33 12.25 - 69.75 <0.0001
sTWEAK ≥ 7,000 pg/mL 2.89 1.96 - 4.27 <0.0001 0.76 0.43 - 1.35 0.350